Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
Marberger
M
M
Department of Urology, University of Vienna, Austria.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D002404:Catheterization / Q000379:methods*; D018120:Finasteride / Q000627:therapeutic use*; D017048:Health Care Costs; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000601:surgery*
D000317:Adrenergic alpha-Antagonists; D018120:Finasteride